skip to primary navigationskip to content
 

Dr Liddicoat to speak at Molecular Med Tri-Con 2017

When Feb 23, 2017
from 02:00 PM to 02:30 PM
Where Moscone Conference Centre, San Francisco
Add event to calendar vCal
iCal

Dr Liddicoat will present a detailed quantitative study of how the Supreme Court decision of Association for Molecular Pathology v. Myriad Genetics Inc. has affected claims to naturally occurring nucleotides as composition of matter. This study focuses on patent applications that were pending when the case was decided and how the applicants have amended their claims to comply with the holding in Myriad. A descriptive statistical analysis of how claims have changed post-Myriad will be presented, as well as several case studies demonstrating these changes.

Upcoming events

Gene Editing: From Innovative Science to Effective Policy

May 25, 2017

The Møller Centre, Cambridge

Genetic Databases: Who is Liable, When, and For What?

May 26, 2017

Alison Richard Building, Sidgwick Site, Cambridge

Upcoming events